Prokaryotic DNA polymerase represents 34.1% within the value segment and molecular diagnostics companies account for 39.1% of the end users category in 2025. The DNA polymerase market was valued at USD 374.8 million in 2024 and is forecast to post a 6.2% CAGR between 2025 and 2035.